Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review

The available data suggest that QFM may be able to identify overly immunosuppressed individuals at higher risk of infection; additional studies are needed to further evaluate its predictive utility in transplant and other settings.